Eli Lilly's 340B claims data deadline has passed, but the pharma company isn't saying what's next as hospitals and legal experts brace for litigation.
Eli Lilly’s deadline has passed for hospitals to comply with its new 340B claims data policy, and for now the pharma company is staying mum …
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
Eli Lilly threatens to cut 340B discounts for hospitals that won't share claims data, as the American Hospital Association calls…
Eli Lilly and Company said Monday evening that it will soon end 340B discount pricing for some of the hospitals that have not met…
Eli Lilly has told more than 1,000 hospitals participating in the 340B drug discount program to submit claims data over the next…
Select hospitals have refused to share data to prove they’re not double-dipping drug discounts, Lilly said. Hospitals, which have…
Making good on its threat, Eli Lilly has begun eliminating mandated price breaks to a few dozen hospitals that participate in a…
Lilly gave hospitals participating in a federal drug discount program five days to submit claims data or it will stop the price…
